CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics
New Delhi: The Competition Commission of India (CCI) approves merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for acquisition of approximately 15% equity shareholding of Biocon Biologics …
CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics Read More